French pharmaceutical giant Sanofi announced Monday that it will acquire U.S.-based Blueprint Medicines for $9.1 billion to strengthen its portfolio in rare immunological diseases.
France-based pharmaceutical company Sanofi announced Monday that it will acquire U.S.-based Blueprint Medicines Corporation for $9.1 billion, in a strategic move to bolster its presence in rare immunological diseases.
Blueprint, a biopharmaceutical company specializing in systemic mastocytosis (SM) and other KIT-driven diseases, accepted Sanofi’s offer of $129 per share in cash. The offer represents a 27% premium over Blueprint’s last closing price of $101.35 on Friday.
The acquisition includes Ayvakit (avapritinib), a treatment for SM approved in both the U.S. and EU, along with a robust early- and late-stage immunology pipeline.
“Blueprint’s established relationships with allergists, dermatologists, and immunologists are expected to enhance Sanofi’s growing immunology portfolio,” the French company said in a statement.
The transaction is expected to close in the third quarter of 2025, pending regulatory approvals.
As part of the deal, Blueprint shareholders will also receive one non-tradeable contingent value right (CVR), entitling them to potential milestone payments of $2 and $4 per CVR based on future achievements.
Blueprint is currently the only company with an approved drug for systemic mastocytosis - a rare disorder caused by excess mast cells - and is also developing next-generation therapies for SM and other immune disorders.
The acquisition marks the largest healthcare M&A deal in Europe so far this year. It follows Sanofi’s recent purchase of Vigil Neuroscience for $470 million last month - the second time the French company has acquired Vigil in 2025, after an initial purchase in January.
U.S. President Donald Trump says Israeli Prime Minister Benjamin Netanyahu will visit Washington next week as tensions continue to rise across the Mid...
India's Education Minister, Dharmendra Pradhan, resigned on Saturday, marking a significant victory for youth protesters who had been demanding that h...
Paramount Skydance agreed to pause its acquisition of Warner Bros Discovery until after a ruling on a challenge by states to the deal, plunging the ...
Start your day informed with AnewZ Morning Brief. Here are the top news stories for the 24th July, covering the latest developments you need to know.
U.S. strikes on Iran entered a 12th consecutive night, while Yemen's Houthis said they attacked two Saudi oil tankers in the Red Sea, urging President Donald Trump to warn Tehran it would be held responsible for any future Houthi attacks.
The U.S. military said it completed a fresh wave of strikes on Iran late on Thursday, marking the 13th consecutive night of American attacks. The latest operation lasted more than two hours, according to U.S. Central Command.
Aleksandar Vučić's visit to Kyiv on 15 July appeared to send a geopolitical signal. But the significance of the trip lies less in the journey itself than in the limits Serbia carefully observed.
Spain has declared a national emergency and evacuated more than 10,000 people after uncontrolled wildfires reached the outskirts of Madrid. Emergency crews have rescued residents as multiple blazes continue to spread across the region.
A global shift towards healthier diets, more efficient farming and reduced food waste could cut greenhouse gas emissions from agriculture-related land-use change by 85% by 2050, according to a study published last week in the journal Nature.
Venezuelan health authorities have confirmed that three people have died from hantavirus infections, while stressing there is no evidence that the disease is spreading between people in the country.
Up to five cups of caffeinated coffee a day appears to be safe for most adults and may even help protect against heart disease and stroke, according to new research. Experts say energy drinks are a different story and may increase heart risks.
Portugal has become the first European Union member state to join HealthAI's Global Regulatory Network (GRN), as Europe prepares to implement new rules governing artificial intelligence across the bloc.
Nearly 7,000 people across the United States may have been infected with cyclosporiasis, a foodborne parasitic illness that causes prolonged diarrhoea. The outbreak has spread to 34 states, with health officials still trying to identify its source.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment